🇺🇸 FDA
Patent

US 9192644

Bioavailable curcuminoid formulations for treating Alzheimer's disease and other age-related disorders

granted A61KA61K36/9066A61P

Quick answer

US patent 9192644 (Bioavailable curcuminoid formulations for treating Alzheimer's disease and other age-related disorders) held by The Regents of the University of California expires Mon Nov 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K36/9066, A61P, A61P25/28